What is EUBGD's earnings per share (EPS)?

EUBGD (EUBGD) reported diluted earnings per share of $0.01 for fiscal year 2025. That is unchanged from the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

EUBGD Financials

EUBGD

FY2025 annual

Revenue $5.7M +7.7% YoY

Net Income $1.9M +28.1% YoY

EPS (Diluted) $0.01 0.0% YoY

Free Cash Flow $2.4M YoY not available

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 15, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 15, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EUBGD SEC filings page.

EUBGD (EUBGD) reported $5.7M in revenue for fiscal year 2025, up 7.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EUBGD FY2025 2026-10-04

The business earns high margins, needs little reinvestment, and converts accounting profit into cash without relying heavily on liabilities.

In FY2025, operating cash flow of $2.5M exceeded net income of $1.9M, so reported earnings were not merely accrual-driven. Free cash flow of $2.4M stayed close to operating cash flow because capital expenditures were just $117K, revealing a model that currently requires little annual reinvestment.

The margin structure strengthened during the three-year span: gross margin rose from 81.1% in FY2022 to 88.3% in FY2025, meaning the revenue recovery came with better economics per dollar sold. Operating margin reached 51.9% in FY2025, up from 31.9% in FY2022, consistent with improved cost absorption or mix rather than proving pricing alone.

The balance sheet is lightly burdened: FY2025 debt-to-equity was 0.2x and current ratio was 8.8x, giving liabilities a limited role in funding day-to-day operations. Yet current ratio fell from 14.4x in FY2024 to 8.8x in FY2025, so liquidity became less excessive even as the company remained well above a tight short-term position.

Financial Health Signals

Financial health score not available

EUBGD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

5/8

EUBGD passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.32x

For every $1 of reported earnings, EUBGD generates $1.32 in operating cash flow ($2.5M OCF vs $1.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$738K

YoY-23.3%

QoQ-68.7%

5Y CAGR-17.9%

EUBGD generated $738K in revenue in Q1 2026. This represents a decrease of 23.3% from the same quarter a year earlier. Against the prior quarter it is down 68.7%.

EBITDA

$9K

YoY-97.2%

EUBGD's EBITDA was $9K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 97.2% from the same quarter a year earlier.

Net Income

$78K

YoY-57.6%

QoQ-91.4%

5Y CAGR-39.6%

EUBGD reported $78K in net income in Q1 2026. This represents a decrease of 57.6% from the same quarter a year earlier. Against the prior quarter it is down 91.4%.

EPS (Diluted)

$0.00

EUBGD earned $0.00 per diluted share (EPS) in Q1 2026.

Cash & Balance Sheet

Free Cash Flow

-$364K

EUBGD recorded an outflow of $364K in free cash flow in Q1 2026, representing a cash shortfall after capex.

Cash & Debt

$10.6M

YoY+19.0%

QoQ-3.7%

5Y CAGR+11.0%

EUBGD held $10.6M in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding

170M

QoQ0.0%

EUBGD had 170M shares outstanding in Q1 2026. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

80.5%

YoY-1.6pp

QoQ-10.0pp

5Y change-8.4pp

EUBGD's gross margin was 80.5% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 10.0 percentage points.

Operating Margin

0.5%

YoY-33.7pp

QoQ-57.9pp

5Y change-72.7pp

EUBGD's operating margin was 0.5% in Q1 2026, reflecting core business profitability. This is down 33.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 57.9 percentage points.

Net Margin

10.5%

YoY-8.5pp

QoQ-27.7pp

5Y change-38.2pp

EUBGD's net profit margin was 10.5% in Q1 2026, showing the share of revenue converted to profit. This is down 8.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 27.7 percentage points.

Return on Equity

0.7%

YoY-1.4pp

QoQ-7.9pp

5Y change-14.0pp

EUBGD's ROE was 0.7% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.9 percentage points.

Capital Allocation

Capital Expenditures

$43K

EUBGD invested $43K in capex in Q1 2026, funding long-term assets and infrastructure.

R&D Spending

Not reported for Q1 2026.

Share Buybacks

Not reported for Q1 2026.

EUBGD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EUBGD quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20
Revenue	$5.5M	$5.7M+7.7%	$5.3M-15.5%	$6.2M+77.9%	$3.5M-37.8%	$5.6M-38.6%	$9.2M
Cost of Revenue	$639K	$668K-2.8%	$687K+44.8%	$475K-28.5%	$663K-63.7%	$1.8M+176.2%	$661K
Gross Profit	$4.8M	$5.0M+9.3%	$4.6M-20.4%	$5.8M+102.7%	$2.8M-25.4%	$3.8M-55.3%	$8.5M
SG&A Expenses	$2.2M	$2.1M+3.1%	$2.0M+5.5%	$1.9M+12.9%	$1.7M+0.9%	$1.7M+78.4%	$935K
Operating Income	$2.6M	$2.9M+14.2%	$2.6M-33.2%	$3.9M+244.9%	$1.1M-40.7%	$1.9M-74.5%	$7.4M
EBITDA	N/A	$3.0M+13.3%	$2.6M-33.3%	$3.9M+227.9%	$1.2M-39.0%	$2.0M-73.5%	$7.4M
Interest Expense	N/A	N/A	N/A	$72K-39.7%	$119K	N/A	N/A
Income Tax	$1.3M	$1.4M+4.9%	$1.3M-20.4%	$1.7M+135.7%	$701K-29.1%	$989K-60.5%	$2.5M
Net Income	$1.8M	$1.9M+28.1%	$1.5M-34.8%	$2.3M+464.1%	$405K-62.8%	$1.1M-78.1%	$5.0M
EPS (Basic)	N/A	$0.010.0%	$0.01	$0.00	$0.00	$0.00	$0.00
EPS (Diluted)	—	$0.010.0%	$0.01	$0.00	$0.00	$0.00-100.0%	$1000000.00
Diluted Shares (Avg)	N/A	170M0.0%	170M	1.70B0.0%	1.70B0.0%	1.70B	0

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'25	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'24
Revenue	$738K-23.3%	$2.4M+118.5%	$1.2M-27.1%	$1.1M-9.6%	$962K-23.7%	$1.1M-34.2%	$1.7M-2.6%	$1.3M-25.9%
Cost of Revenue	$144K-16.5%	$224K+26.6%	$137K-23.4%	$134K-20.8%	$172K+6.7%	$177K+28.6%	$179K+57.3%	$170K+56.3%
Gross Profit	$594K-24.8%	$2.1M+136.5%	$1.1M-27.5%	$1.0M-7.8%	$790K-28.1%	$903K-39.9%	$1.5M-6.9%	$1.1M-31.5%
SG&A Expenses	$590K+28.0%	$758K+8.0%	$386K-9.2%	$462K+1.4%	$461K+9.1%	$702K-0.6%	$425K+11.9%	$456K+16.7%
Operating Income	$4K-98.9%	$1.4M+585.6%	$694K-34.8%	$547K-14.4%	$329K-51.4%	$201K-75.3%	$1.1M-12.0%	$639K-46.8%
EBITDA	$9K-97.2%	N/A	N/A	N/A	$338K-51.5%	N/A	N/A	N/A
Income Tax	$143K-27.3%	$614K+92.7%	$289K-30.2%	$282K-1.7%	$197K-33.8%	$319K-25.2%	$414K-13.6%	$286K-37.2%
Net Income	$78K-57.6%	$904K+1356.4%	$395K-43.8%	$423K+21.3%	$183K-50.9%	$62K-85.2%	$704K-5.1%	$348K-49.5%
EPS (Basic)	$0.00	N/A	$0.00	$0.00	$0.00	N/A	$0.00	$0.00
EPS (Diluted)	$0.00	N/A	$0.00	$0.00	$0.00	N/A	$0.00	$0.00
Diluted Shares (Avg)	170M	N/A	1.70B0.0%	1.70B0.0%	170M-90.0%	N/A	1.70B0.0%	1.70B0.0%

Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.

EUBGD Balance Sheet

EUBGD quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20
Total Assets	$12.2M+30.3%	$9.4M-7.6%	$10.2M+30.7%	$7.8M-5.2%	$8.2M+6.2%	$7.7M
Current Assets	$11.7M+27.0%	$9.2M-8.1%	$10.0M+33.7%	$7.5M-3.5%	$7.8M+5.8%	$7.3M
Cash & Equivalents	$11.0M+29.8%	$8.5M-9.0%	$9.3M+29.6%	$7.2M-6.0%	$7.6M+98.9%	$3.8M
Accounts Receivable	$558K+13.5%	$491K-22.3%	$633K+169.2%	$235K+245.9%	$68K-66.4%	$202K
Total Liabilities	$1.8M+83.4%	$977K-5.2%	$1.0M+16.0%	$889K-38.2%	$1.4M-33.2%	$2.2M
Current Liabilities	$1.3M+107.2%	$640K-24.4%	$847K+23.0%	$689K-31.8%	$1.0M-33.9%	$1.5M
Non-Current Liabilities	$466K+38.2%	$337K+83.0%	$184K-8.2%	$201K-53.3%	$430K-31.4%	$627K
Total Equity	$10.4M+24.2%	$8.4M-7.9%	$9.1M+32.6%	$6.9M+1.8%	$6.8M+21.4%	$5.6M
Retained Earnings	$3.5M+118.7%	$1.6M-31.1%	$2.3M+4834.0%	$47K+113.2%	-$357K+75.2%	-$1.4M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'25	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'24
Total Assets	$11.7M+23.8%	$12.2M+30.3%	$10.3M	$9.7M	$9.5M	$9.4M-7.6%	N/A	N/A
Current Assets	$11.2M+19.8%	$11.7M+27.0%	$10.2M	$9.6M	$9.3M	$9.2M-8.1%	N/A	N/A
Cash & Equivalents	$10.6M+19.0%	$11.0M+29.8%	$9.6M+15.6%	$9.2M-8.8%	$8.9M-7.9%	$8.5M-9.0%	$8.3M-5.0%	$10.0M+24.4%
Accounts Receivable	$408K+29.0%	$558K+13.5%	$507K	$373K	$316K	$491K-22.3%	N/A	N/A
Total Liabilities	$1.2M+37.5%	$1.8M+83.4%	$795K	$687K	$865K	$977K-5.2%	N/A	N/A
Current Liabilities	$960K+73.7%	$1.3M+107.2%	$570K	$516K	$553K	$640K-24.4%	N/A	N/A
Non-Current Liabilities	$230K-26.4%	$466K+38.2%	$225K	$171K	$313K	$337K+83.0%	N/A	N/A
Total Equity	$10.5M+22.5%	$10.4M+24.2%	$9.5M+12.4%	$9.0M-7.8%	$8.6M-9.0%	$8.4M-7.9%	$8.4M-2.2%	$9.8M+23.6%
Retained Earnings	$3.6M+100.6%	$3.5M+118.7%	$2.6M	$2.2M	$1.8M	$1.6M-31.1%	N/A	N/A

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Goodwill, Long-Term Debt.

EUBGD Cash Flow Statement

EUBGD quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20
Operating Cash Flow	$1.8M	$2.5M+85.2%	$1.4M-41.5%	$2.3M+1774.0%	-$139K-130.8%	$452K-93.0%	$6.5M
Depreciation & Amortization	N/A	$34K-31.2%	$50K-36.8%	$79K-3.6%	$82K-1.6%	$83K+159.6%	$32K
Capital Expenditures	N/A	$117K	N/A	$2K-81.1%	$10K	N/A	$369K
Free Cash Flow	N/A	$2.4M	N/A	$2.3M+1663.5%	-$149K	N/A	$6.1M
Investing Cash Flow	N/A	-$117K	N/A	-$2K+81.1%	-$10K-100.3%	$3.3M+196.3%	-$3.4M
Financing Cash Flow	N/A	N/A	-$2.2M-1244.9%	-$164K-4608.9%	-$3K+53.8%	-$8K-104.4%	$170K
Dividends Paid	N/A	N/A	$2.2M	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'25	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'24
Operating Cash Flow	-$321K-175.5%	$1.5M+405.0%	$334K+14.5%	$241K-31.5%	$424K+1.9%	$301K-44.7%	$291K-55.9%	$351K-66.2%
Depreciation & Amortization	$6K-40.6%	N/A	N/A	N/A	$10K-55.6%	N/A	N/A	N/A
Capital Expenditures	$43K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	-$364K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$93K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	$0-100.0%	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A

Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.

EUBGD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EUBGD quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20
Gross Margin	88.3%+1.3pp	87.0%-5.4pp	92.4%+11.3pp	81.1%+13.5pp	67.6%-25.2pp	92.8%
Operating Margin	51.9%+2.9pp	48.9%-13.0pp	61.9%+30.0pp	31.9%-1.5pp	33.5%-47.1pp	80.6%
Net Margin	33.5%+5.3pp	28.2%-8.4pp	36.6%+25.0pp	11.5%-7.7pp	19.3%-34.8pp	54.1%
Return on Equity	18.3%+0.6pp	17.7%-7.3pp	25.0%+19.1pp	5.9%-10.2pp	16.1%-73.1pp	89.2%
Return on Assets	15.6%-0.3pp	15.8%-6.6pp	22.5%+17.3pp	5.2%-8.0pp	13.3%-51.1pp	64.3%
Current Ratio	8.82-5.6x	14.40+2.6x	11.84+0.9x	10.89+3.2x	7.70+2.9x	4.81
Debt-to-Equity	0.17+0.1x	0.120.0x	0.110.0x	0.13-0.1x	0.21-0.2x	0.39
Asset Turnover	0.46-0.1x	0.56-0.1x	0.61+0.2x	0.45-0.2x	0.69-0.5x	1.19
FCF Margin	42.3%	N/A	37.2%+41.5pp	-4.2%	N/A	66.6%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'25	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'24
Gross Margin	80.5%-1.6pp	90.5%+6.9pp	88.7%-0.5pp	88.2%+1.7pp	82.1%-5.1pp	83.6%-8.0pp	89.3%-4.1pp	86.6%-7.1pp
Operating Margin	0.5%-33.7pp	58.4%+39.8pp	57.0%-6.8pp	47.8%-2.7pp	34.2%-19.5pp	18.6%-30.9pp	63.8%-6.8pp	50.5%-19.9pp
Net Margin	10.5%-8.5pp	38.3%+32.5pp	32.4%-9.7pp	37.0%+9.4pp	19.1%-10.6pp	5.8%-19.8pp	42.1%-1.1pp	27.6%-12.9pp
Return on Equity	0.7%-1.4pp	8.7%+7.9pp	4.2%-4.2pp	4.7%+1.1pp	2.1%-1.8pp	0.7%-3.9pp	8.3%-0.3pp	3.6%-5.2pp
Return on Assets	0.7%-1.3pp	7.4%+6.7pp	3.8%	4.4%	1.9%	0.7%-3.5pp	N/A	N/A
Current Ratio	11.62-5.2x	8.82-5.6x	17.86	18.56	16.85	14.40+2.6x	N/A	N/A
Debt-to-Equity	0.110.0x	0.17+0.1x	0.08	0.08	0.10	0.120.0x	N/A	N/A
Asset Turnover	0.060.0x	0.19+0.1x	0.12	0.12	0.10	0.120.0x	N/A	N/A
FCF Margin	-49.3%	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Where EUBGD Ranks

Frequently Asked Questions

What is EUBGD's annual revenue?

EUBGD (EUBGD) reported $5.7M in total revenue for fiscal year 2025. This represents a 7.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is EUBGD's revenue growing?

EUBGD (EUBGD) revenue grew by 7.7% year-over-year, from $5.3M to $5.7M in fiscal year 2025.

Is EUBGD profitable?

Yes, EUBGD (EUBGD) reported a net income of $1.9M in fiscal year 2025, with a net profit margin of 33.5%.

What is EUBGD's EBITDA?

EUBGD (EUBGD) had EBITDA of $3.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is EUBGD's gross margin?

EUBGD (EUBGD) had a gross margin of 88.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is EUBGD's operating margin?

EUBGD (EUBGD) had an operating margin of 51.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is EUBGD's net profit margin?

EUBGD (EUBGD) had a net profit margin of 33.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is EUBGD's return on equity (ROE)?

EUBGD (EUBGD) has a return on equity of 18.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is EUBGD's free cash flow?

EUBGD (EUBGD) generated $2.4M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is EUBGD's operating cash flow?

EUBGD (EUBGD) generated $2.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are EUBGD's total assets?

EUBGD (EUBGD) had $12.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What are EUBGD's capital expenditures?

EUBGD (EUBGD) invested $117K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does EUBGD have outstanding?

EUBGD (EUBGD) had 170M shares outstanding as of fiscal year 2025.

What is EUBGD's current ratio?

EUBGD (EUBGD) had a current ratio of 8.82 as of fiscal year 2025, which is generally considered healthy.

What is EUBGD's debt-to-equity ratio?

EUBGD (EUBGD) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is EUBGD's return on assets (ROA)?

EUBGD (EUBGD) had a return on assets of 15.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is EUBGD's Piotroski F-Score?

EUBGD (EUBGD) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are EUBGD's earnings high quality?

EUBGD (EUBGD) has an earnings quality ratio of 1.32x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.